Skip to main content
Equibles

HANTZ FINANCIAL SERVICES, INC.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1071061 SOUTHFIELD, MI
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,277,508
+$325,971 QoQ
Shares Held
16,664
-6.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HANTZ FINANCIAL SERVICES, INC. holds $29,893,018 across 61 Biotechnology names. VRTX ranks #1 (27.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		16,664 $8,277,508
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,883 $4,781,259
3 HALO
Halozyme Therapeutics, Inc.
 58,496 $4,578,481
4 ARGX
Argenx SE
 2,816 $2,612,600
5 ROIV
Roivant Sciences Ltd.
 34,865 $1,233,872
6 JAZZ
Jazz Pharmaceuticals plc
 3,961 $954,482
7 EXEL
Exelixis, Inc.
 16,074 $874,586
8 CYTK
Cytokinetics Inc
 10,063 $857,266

All Filings in VRTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,277,508 16,664
2026-03-31 $7,951,537 17,807
2025-12-31 $3,260,111 7,191
2025-09-30 $2,439,917 6,230
2025-06-30 $608,143 1,366
2025-03-31 $670,990 1,384
2024-12-31 $506,596 1,258
2024-09-30 $1,648,243 3,544
2024-06-30 $1,628,802 3,475
2024-03-31 $15,884 38
2023-12-31 $15,461 38
2023-09-30 $13,214 38
2023-06-30 $13,372 38
2021-12-31 $19,983 91
2021-09-30 $18,139 100
2021-06-30 $503,066 2,495
2021-03-31 $395,182 1,839
2020-12-31 $271,081 1,147
2020-09-30 $106,671 392